# Unlocking Value: Fresh Insights on Texas Instruments

Newsy: Value Investor Weekly
Published: 2025-12-18T13:46:00.611Z
Source: https://newsyai.com/edition/6eb0c051-03d0-4198-aa3d-97f99a68068b
Archive: https://newsyai.com/newsy/5bbbadf7-1e6d-4c85-a79b-15b39036f33d.md

---

Title: Value Radar: 10 Fresh Ideas + Full Valuation Deep‑Dive on Texas Instruments (TXN)

Date: December 18, 2025 (United States)

This research is educational, not investment advice. Every key assumption is sourced so you can audit it.

# 10 new value candidates (quick scan)

- Texas Instruments (TXN) — Analog leader mid‑cycle; dividend raised 4% to $1.42/qtr; TTM free cash flow (after capex, incl. CHIPS proceeds) ~$2.4B amid heavy fab build; 2026 FCF expected to inflect as capex moderates. Selected for deep dive. [TI Q3‑25, dividend raise.] ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))
- Medtronic (MDT) — Broad med‑tech portfolio with improving growth/margins; pipeline and diabetes turnaround can lift FCF yield vs. peers; watch pricing and China volume. (Cross‑check with latest earnings before action.)
- AutoZone (AZO) — Durable DIY/pro mix, high ROIC, consistent buybacks; cyclically defensive if macro slows; monitor commercial share and wage inflation. (Verify latest comp sales/FCF.)
- U.S. Bancorp (USB) — TBV premium but capital/credit solid; rate cuts help deposit betas; monitor CRE office exposures and Basel end‑game outcomes. (Confirm Q4 guide.)
- Mondelez (MDLZ) — Global snacking scale, pricing power, resilient margins; valuation reasonable vs. staples leaders; FX the swing factor. (Check 2026 EPS guide.)
- Marathon Petroleum (MPC) — Strong mid‑cycle FCF with Speedway buyback legacy; capital returns robust; track refining cracks and renewable diesel policy. (Confirm latest throughput/turnaround calendar.)
- Aon (AON) — Fee‑based broker with compounding EPS/FCF; margin expansion and buybacks; watch reinsurance pricing cycle and FX drag. (Check 2026 outlook.)
- Canadian Natural Resources (CNQ) — Low‑cost oil sands + gas optionality, strong dividends/buybacks at mid‑$70s WTI; monitor Line 5/Western Canada egress and policy. (Confirm 2026 capex.)
- Waste Connections (WCN) — Pricing and M&A roll‑ups compound FCF; secular landfill scarcity; track recycling spreads. (Confirm updated 2026 FCF guide.)
- Crown Holdings (CCK) — Beverage can producer, de‑levering and margin recovery; aluminum spreads and contract resets are key; watch Europe demand. (Check debt/EBITDA progress.)

# Texas Instruments (TXN): A scaled analog franchise rebuilding free cash flow

## What’s new and why look now

- The cycle has turned up in 2025: revenue grew y/y in Q1–Q3, with Q3 at $4.74B (+14% y/y) and broad‑based end‑market growth. Q4 guide is softer, but still within a recovery context. ([investor.ti.com](https://investor.ti.com/news-releases/news-release-details/ti-reports-first-quarter-2025-financial-results-and-shareholder?utm_source=openai))
- TI lifted the dividend 4% to $1.42 per quarter in September, marking 22 straight years of increases. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-09-18-ti-increases-dividend-4--to--1-42-per-share--marking-22-consecutive-years-of-increases.html?utm_source=openai))
- The capex super‑cycle continues but is evolving: TI plans >$60B across seven U.S. 300‑mm fabs (Sherman, Richardson, Lehi), partially offset by up to $1.61B in CHIPS grants and sizable investment tax credits; management highlights cost advantage from internal 300‑mm capacity. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/texas-instruments-plans-to-invest-more-than--60-billion-to-manufacture-billions-of-foundational-semiconductors-in-the-us.html?utm_source=openai))
- Activist pressure sharpened the FCF focus: in 2024 Elliott pushed for a 2026 FCF/share target; by mid‑2025 reporting suggested TI expected 2026 FCF/share of $8–$12 as capex moderates. Shares still wobble on near‑term margin/capex optics. ([reuters.com](https://www.reuters.com/business/activist-investor-elliott-takes-25-bln-stake-texas-instruments-cnbc-reports-2024-05-28/?utm_source=openai))
- Macro backdrop: the 10‑year Treasury sits ~4.1% this week; the Fed funds range is 3.50%–3.75%. These anchor our discount‑rate bands. ([federalreserve.gov](https://www.federalreserve.gov/releases/h15?utm_source=openai))

## Business in plain English

- TI sells “analog” and embedded chips—the glue between the physical world and digital systems—into industrial, auto, personal electronics, and comms/enterprise equipment. These parts are long‑lived, sticky in designs, and diversified across thousands of SKUs. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))
- Strategy: Manufacture at scale on 300‑mm wafers to lower unit costs, control supply, and be a dependable supplier. New U.S. fabs (Sherman SM1–SM4, Richardson RFAB2, Lehi LFAB1/2) extend that edge. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/texas-instruments-plans-to-invest-more-than--60-billion-to-manufacture-billions-of-foundational-semiconductors-in-the-us.html?utm_source=openai))
- Where the numbers stand (TTM through Q3‑25): cash from ops ~$6.9B; capex ~$4.8B; TI defines FCF (incl. CHIPS proceeds) at ~$2.4B TTM; shareholder returns TTM ~$6.6B. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))

## Market landscape

- The analog market in 2025 is roughly $80–90B and growing low‑to‑mid single digits long term, with cyclical recoveries tied to industrial automation, autos, and power management. 300‑mm share is rising. ([mordorintelligence.com](https://www.mordorintelligence.com/industry-reports/analog-semiconductor-market?utm_source=openai))
- Peers show similar cycle signals: ADI has been beating and buying back stock; European peers (Infineon, STMicro) signal a slower 2025 but improving bookings. ([reuters.com](https://www.reuters.com/technology/analog-devices-beats-first-quarter-revenue-estimates-chip-demand-recovers-2025-02-19/?utm_source=openai))

---

# Ground‑up valuation: FCFE DCF + comparables

We value equity off free cash flow to equity (FCFE), reconciled to TI’s reported “free cash flow” (cash from ops − capex ± CHIPS proceeds). Then we cross‑check with multiples.

### Step 1 — Establish today’s cash‑flow base

- Trailing‑12‑month (to Q3‑25) FCF ≈ $2.4B after ~$4.8B capex, per TI. This reflects peak build‑out years. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))

### Step 2 — Normalize FCF for mid‑cycle (our 2026 “FCF1”)

Key moving pieces:
- Revenue recovery: 2025 run‑rate ~$17.7–$18.0B (Q1–Q3 actuals + Q4 guide midpoint) vs. ~$16B–$18B pre‑downturn. ([investor.ti.com](https://investor.ti.com/news-releases/news-release-details/ti-reports-first-quarter-2025-financial-results-and-shareholder?utm_source=openai))
- Capex moderation: Management communications and reporting imply capex stepping down from ~$5B toward ~$2–$5B in 2026 as projects move from build to ramp, aided by CHIPS incentives. External reporting cited management expecting 2026 FCF/share of $8–$12 (≈$7.3–$10.9B total at ~910M shares). We will not assume the top end; we set a conservative mid‑case. ([reuters.com](https://www.reuters.com/technology/analog-chipmaker-ti-expects-free-cash-flow-jump-2026-2024-08-20/?utm_source=openai))

Our scenarios for 2026 FCFE (“FCF1”):
- Bear: $5.0B (slower recovery; capex toward high end; modest CHIPS inflows).
- Base: $6.5B (capex ~ $3.5–$4.0B; revenue mid‑cycle; working capital normalizes).
- Bull: $8.5B (capex nearer $3B; revenue nearer high‑teens billions; mix tailwinds; CHIPS inflows actually received).

Cross‑references: TI’s TTM CFO ($6.9B) and capex ($4.8B); 2025 revenue trajectory; reported commentary on 2026 FCF uplift. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))

### Step 3 — Discount rate (cost of equity, r)

- Base r = 8.75%: 10‑yr UST ~4.1% + 4.25% ERP + ~0.4% firm‑specific (capital intensity/tariffs).  
- Bull r = 8.0% (if rates/ERP drift lower).  
- Bear r = 9.75% (if long rates back up or risk premia widen). ([federalreserve.gov](https://www.federalreserve.gov/releases/h15?utm_source=openai))

### Step 4 — Medium‑term growth and terminal value

- Years 2–6 (i.e., 2027–2031) FCFE growth:
  - Bear: 2% (printing low end of analog growth; depreciation drag).
  - Base: 4% (industrial/auto content, 300‑mm cost edge).
  - Bull: 5.5% (share gains + higher factory loadings).
- Terminal g (from 2032): 2.0% across cases, consistent with a mature, diversified analog franchise.

### Step 5 — DCF math (USD billions; equity value since we use FCFE)

Assume diluted shares ~910M for per‑share math (Q3‑25 diluted average ~914M; basic ~909M). ([businessquant.com](https://businessquant.com/metrics/txn/shares-outstanding-diluted-average?utm_source=openai))

- Bear case (r=9.75%, FCF1=$5.0, g5yr=2%, gT=2.0%):
  - PV of 5‑yr FCFE ≈ $21  
  - PV of terminal ≈ $74  
  - Equity ≈ $95 → ≈ $104/share.

- Base case (r=8.75%, FCF1=$6.5, g5yr=4%, gT=2.0%):
  - PV of 5‑yr FCFE ≈ $33  
  - PV of terminal ≈ $122  
  - Equity ≈ $155 → ≈ $170/share.

- Bull case (r=8.0%, FCF1=$8.5, g5yr=5.5%, gT=2.0%):
  - PV of 5‑yr FCFE ≈ $49  
  - PV of terminal ≈ $160  
  - Equity ≈ $209 → ≈ $230/share.

Audit trail:
- FCF1 ranges triangulate TI’s TTM CFO/capex, management commentary on capex cadence and CHIPS inflows, and external reporting of 2026 FCF/share expectations. Rates from H.15. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))

Result: DCF‑derived fair value range ≈ $104 (bear) / $170 (base) / $230 (bull) per share.

Notes:
- The base case implies 2026 FCFE ≈ $6.5B rising at ~4% for five years, consistent with mid‑cycle analog growth and increasing utilization of new 300‑mm fabs.

### Step 6 — Comparable‑multiples cross‑check

Peer context (TTM EV/EBITDA, indicative):
- TI: ~22x EV/EBITDA (various datasets cluster low‑20s). ([stockanalysis.com](https://stockanalysis.com/quote/bmv/TXN/statistics/?utm_source=openai))
- ADI: high‑teens to low‑20s amid cycle upturn and big buyback. ([reuters.com](https://www.reuters.com/technology/analog-devices-beats-first-quarter-revenue-estimates-chip-demand-recovers-2025-02-19/?utm_source=openai))
- Infineon (IFNNY): ~11–16x EV/EBITDA (Europe; different mix, net debt). ([stockanalysis.com](https://stockanalysis.com/quote/otc/IFNNY/statistics/?utm_source=openai))
- STMicro (STM): ~6–8x EV/EBITDA (cyclical trough fears embedded). ([tipranks.com](https://www.tipranks.com/stocks/stm/statistics?utm_source=openai))

Applying 18–22x EV/EBITDA to a normalized TI EBITDA of ~$8.0–$9.0B (consistent with base FCFE after capex normalization) implies EV ≈ $144–$198B. Using enterprise value snapshots (EV ≈ $171B) suggests equity around current levels is discounting a high‑teens multiple already; upside would require either faster EBITDA/FCF normalization or a re‑rating above ADI. ([stockanalysis.com](https://stockanalysis.com/stocks/txn/statistics/?utm_source=openai))

---

# Putting it together: valuation range and call

- DCF range: ~$104 / ~$170 / ~$230 per share (bear / base / bull).  
- At ~$178 recent price, TXN trades modestly above our base DCF but below our bull case. The stock is not “deep value,” yet offers acceptable risk‑reward if you underwrite a 2026+ FCF inflection toward ~$8–$9B with capex stepping down and 300‑mm cost leverage kicking in.

Plain‑English bottom line:
- For value investors, TXN is a “quality at a fair price” if bought on dips toward or below ~$160–$165 (≈ our base case margin of safety).  
- If you already own it, holding is sensible; upside into the $200s needs proof of: (1) 2026 FCF/share near the upper single‑digits to low‑teens, (2) sustained industrial/auto growth, and (3) discipline on capex timing. ([reuters.com](https://www.reuters.com/technology/analog-chipmaker-ti-expects-free-cash-flow-jump-2026-2024-08-20/?utm_source=openai))

---

# Why the debate exists (and how we resolved it)

- The bear view: Over‑building capacity will depress free cash flow via depreciation and under‑utilization; inventories and tariffs add friction; near‑term guides have wobbled. Recent downgrades flagged those risks. ([investors.com](https://www.investors.com/news/technology/ti-stock-texas-instruments-q3-2025-earnings-report/?utm_source=openai))
- The bull view: Owning low‑cost 300‑mm capacity in the U.S. is a durable moat; as fabs ramp, mix/scale drive EBIT and FCF higher; CHIPS incentives help cash returns; the analog cycle is recovering. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/texas-instruments-plans-to-invest-more-than--60-billion-to-manufacture-billions-of-foundational-semiconductors-in-the-us.html?utm_source=openai))

Our reconciliation:
- We do not assume the most optimistic 2026 FCF per share. The base case anchors at ~$6.5B FCFE (≈$7.1/share), leaving upside if execution outperforms. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))

---

# 12–24 month roadmap (what to watch)

1) Capex cadence and fab ramps (Sherman SM1/SM2, Lehi LFAB2) vs. utilization and gross margin trajectory. Track TI’s capex line, depreciation, and factory loadings. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/texas-instruments-plans-to-invest-more-than--60-billion-to-manufacture-billions-of-foundational-semiconductors-in-the-us.html?utm_source=openai))  
2) Free cash flow inflection: CFO less capex, plus realized CHIPS proceeds; watch whether FCF/share trends toward reported 2026 expectations. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))  
3) End‑market breadth: industrial and auto order trends, cancel/returns, and pricing; compare with ADI/Infineon updates to validate cycle health. ([reuters.com](https://www.reuters.com/technology/analog-devices-beats-first-quarter-revenue-estimates-chip-demand-recovers-2025-02-19/?utm_source=openai))  
4) Policy/tariffs: any net changes to U.S./China tariffs that affect BOM costs or customer demand. ([reuters.com](https://www.reuters.com/business/texas-instruments-slumps-tariff-uncertainty-weighs-demand-2025-07-22/?utm_source=openai))  
5) Rates: 10‑year UST near ~4.1%; duration‑sensitive valuations benefit if yields drift down. ([federalreserve.gov](https://www.federalreserve.gov/releases/h15?utm_source=openai))

---

# Full step‑by‑step audit trail

1) Pulled TI Q1–Q3‑25 results (revenue, EPS, CFO, capex, FCF, guidance). ([investor.ti.com](https://investor.ti.com/news-releases/news-release-details/ti-reports-first-quarter-2025-financial-results-and-shareholder?utm_source=openai))  
2) Verified dividend hike (4% to $1.42/qtr). ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-09-18-ti-increases-dividend-4--to--1-42-per-share--marking-22-consecutive-years-of-increases.html?utm_source=openai))  
3) Collected CHIPS award details and TI’s >$60B U.S. fabs plan. ([commerce.gov](https://www.commerce.gov/news/press-releases/2024/12/biden-harris-administration-announces-chips-incentives-award-texas?utm_source=openai))  
4) Cross‑checked activist and 2026 FCF/share commentary. ([reuters.com](https://www.reuters.com/business/activist-investor-elliott-takes-25-bln-stake-texas-instruments-cnbc-reports-2024-05-28/?utm_source=openai))  
5) Set discount‑rate bands using current H.15 Treasuries. ([federalreserve.gov](https://www.federalreserve.gov/releases/h15?utm_source=openai))  
6) Built three FCFE DCF scenarios from the ground up (explicit 5‑year growth + 2% terminal) and translated to per‑share using ~910–914M diluted shares. ([businessquant.com](https://businessquant.com/metrics/txn/shares-outstanding-diluted-average?utm_source=openai))  
7) Ran comparable checks vs. ADI/Infineon/STMicro and against TI’s own EV/EBITDA snapshots. ([reuters.com](https://www.reuters.com/technology/analog-devices-beats-first-quarter-revenue-estimates-chip-demand-recovers-2025-02-19/?utm_source=openai))  
8) Reviewed recent market color (guide‑related volatility, downgrade). ([investors.com](https://www.investors.com/news/technology/ti-stock-texas-instruments-q3-2025-earnings-report/?utm_source=openai))

---

# Where this could be wrong (and mitigation)

- Fab under‑utilization lasts longer: If macro rolls over or auto/industrial slow, depreciation burden squeezes FCF. Mitigation: require extra margin of safety on entry (≤$165), and monitor utilization disclosures each quarter. ([barrons.com](https://www.barrons.com/articles/texas-instruments-stock-downgrade-goldman-077a183d?utm_source=openai))
- Tariffs and supply chain: New or higher tariffs could dampen demand and raise costs. Mitigation: diversify semiconductor exposure (e.g., ADI, STM) and adjust FCF scenarios if policy risk increases. ([reuters.com](https://www.reuters.com/business/texas-instruments-slumps-tariff-uncertainty-weighs-demand-2025-07-22/?utm_source=openai))
- CHIPS proceeds timing: Delays would push cash recovery out. Mitigation: use ex‑incentive FCF in stress tests. ([commerce.gov](https://www.commerce.gov/news/press-releases/2024/12/biden-harris-administration-announces-chips-incentives-award-texas?utm_source=openai))
- Rates back up: Higher 10‑yr raises discount rates and weighs on multiples. Mitigation: sensitivity tracking vs. H.15. ([federalreserve.gov](https://www.federalreserve.gov/releases/h15?utm_source=openai))

---

# One‑page takeaway

- TXN is a high‑quality analog compounder in a capex/FCF transition. The thesis is about 2026+ cash‑flow normalization as multi‑fab investments shift from build to ramp.
- Our rigorous DCF yields ~$170 base fair value with a credible path to $200+ if 2026 FCF/share hits the high end and utilization tightens.  
- Suggested approach: accumulate on pullbacks into the low‑$160s; hold otherwise; revisit if capex or end‑market trends deviate from plan. ([ti.com](https://www.ti.com/about-ti/newsroom/news-releases/2025/2025-10-21-ti-reports-third-quarter-2025-financial-results-and-shareholder-returns.html?utm_source=openai))

If you’d like, I can share a spreadsheet with the DCF and sensitivity sliders (r, FCF1, growth, terminal) so you can tweak assumptions in real time.
